Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang, Ziyu Dai, Wantao Wu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 348
Implications of the tumor immune microenvironment for staging and therapeutics
Janis M. Taube, Jérôme Galon, Lynette M. Sholl, et al.
Modern Pathology (2017) Vol. 31, Iss. 2, pp. 214-234
Open Access | Times Cited: 325
Understanding the Molecular Genetics of Basal Cell Carcinoma
Cristina Pellegrini, Maria Giovanna Maturo, Lucia Di Nardo, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2485-2485
Open Access | Times Cited: 217
Characterization of the Immune Microenvironment in Hepatocellular Carcinoma
Mark Yarchoan, Dongmei Xing, Lan Luan, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 23, pp. 7333-7339
Open Access | Times Cited: 135
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Masaru Katoh
Clinical Science (2019) Vol. 133, Iss. 8, pp. 953-970
Closed Access | Times Cited: 90
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
Elisabeth Peer, Suzana Tesanovic, Fritz Aberger
Cancers (2019) Vol. 11, Iss. 4, pp. 538-538
Open Access | Times Cited: 85
Immunotherapy for Non-melanoma Skin Cancer
Sophia Z. Shalhout, Kevin S. Emerick, Howard L. Kaufman, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 81
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021*
I. Nasr, Eric McGrath, Catherine Α. Harwood, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 5, pp. 899-920
Open Access | Times Cited: 80
Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M. Barrios, H. Mytrang, Gregory S. Phillips, et al.
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 5, pp. 1239-1253
Open Access | Times Cited: 77
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1164-1178
Open Access | Times Cited: 53
Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives
Marianela Zambrano‐Román, Jorge Ramón Padilla‐Gutiérrez, Yeminia Valle, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2371-2371
Open Access | Times Cited: 43
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management
Piyu Parth Naik, Munaf B. Desai
Oncology and Therapy (2022) Vol. 10, Iss. 2, pp. 317-335
Open Access | Times Cited: 40
Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
Jennifer A. Bridge, James Lee, Adil Daud, et al.
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 80
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
Sandra Grund‐Gröschke, Georg Stockmaier, Fritz Aberger
Cell Communication and Signaling (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 64
Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy
Michael-Joseph Gorbet, Ashish Ranjan
Pharmacology & Therapeutics (2019) Vol. 207, pp. 107456-107456
Open Access | Times Cited: 62
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Evidio Domingo‐Musibay, Paari Murugan, Alessio Giubellino, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Tumour Microenvironment in Skin Carcinogenesis
Simona Roxana Georgescu, Mircea Tampa, Cristina Iulia Mitran, et al.
Advances in experimental medicine and biology (2020), pp. 123-142
Closed Access | Times Cited: 50
Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility
Christelle Adolphe, Angli Xue, Atefeh Taherian Fard, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 44
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis
Huw Morgan, Elise Rees, Simone Lanfredini, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 21
Open Access | Times Cited: 30
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W. Silk, Christopher A. Barker, Shailender Bhatia, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004434-e004434
Open Access | Times Cited: 28
The emerging roles of Hedgehog signaling in tumor immune microenvironment
Juan Wang, Baiping Cui, Xiaojie Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
Aaron M. Goodman, Shumei Kato, Philip R. Cohen, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1404217-e1404217
Open Access | Times Cited: 56
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature
Francesco Sabbatino, Antonio Marra, Luigi Liguori, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 54
LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation
Hui Li, Jun‐Quan Xia, Fangshi Zhu, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 12, pp. 9997-10004
Closed Access | Times Cited: 50
Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics
Mina Nikanjam, P. R. Cohen, Shumei Kato, et al.
Annals of Oncology (2018) Vol. 29, Iss. 11, pp. 2192-2199
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top